Renaissance Technologies (RenTech)'s INAB Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 12,100 shares of IN8bio, Inc. (INAB) worth $17,061, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Renaissance Technologies (RenTech) has initiated a new position in INAB, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s IN8bio (INAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly IN8bio (INAB) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +12,100 | New Buy | 12,100 | $1.41 |
Renaissance Technologies (RenTech)'s IN8bio Investment FAQs
Renaissance Technologies (RenTech) first purchased IN8bio, Inc. (INAB) in Q2 2026, acquiring 12,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held IN8bio, Inc. (INAB) for 1 quarters since Q2 2026.
Renaissance Technologies (RenTech)'s largest addition to IN8bio, Inc. (INAB) was in Q2 2026, adding 12,100 shares worth $17,061.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 12,100 shares of IN8bio, Inc. (INAB), valued at approximately $17,061.
As of the Q2 2026 filing, IN8bio, Inc. (INAB) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in IN8bio, Inc. (INAB) was 12,100 shares, as reported at the end of Q2 2026.